HomeACIU • NASDAQ
add
AC Immune SA
Previous close
$2.38
Day range
$2.31 - $2.44
Year range
$1.43 - $3.97
Market cap
244.00M USD
Avg Volume
129.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(CHF) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 1.31M | 90.10% |
Operating expense | 3.87M | -14.24% |
Net income | -21.19M | 6.90% |
Net profit margin | -1.62K | 51.03% |
Earnings per share | -0.21 | 8.70% |
EBITDA | -19.02M | 7.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 127.14M | -27.40% |
Total assets | 190.22M | -19.92% |
Total liabilities | 115.48M | 1.20% |
Total equity | 74.74M | — |
Shares outstanding | 100.63M | — |
Price to book | 3.22 | — |
Return on assets | -24.16% | — |
Return on capital | -53.96% | — |
Cash Flow
Net change in cash
(CHF) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -21.19M | 6.90% |
Cash from operations | -15.60M | -121.36% |
Cash from investing | 23.88M | 131.50% |
Cash from financing | -247.00K | -298.39% |
Net change in cash | 5.76M | 205.82% |
Free cash flow | -9.96M | -113.47% |
About
Founded
2003
Website
Employees
153